Supplementary - Hyperkalemia Risk in Women With Stage I and II Chronic Kidney Disease Receiving Spironolactone for Dermatologic Indications

Name: Supplementary - Hyperkalemia Risk in Women With Stage I and II Chronic Kidney Disease Receiving Spironolactone for Dermatologic Indications
Creator: Rebecca Zhang
Published: 2026-07-03T15:22:06.501Z
Keywords: Dermatology, Potassium, Chronic Kidney Disease, Adult Acne

Zhang, Rebecca

doi:10.17632/49gpgn4kxj.1

Supplementary - Hyperkalemia Risk in Women With Stage I and II Chronic Kidney Disease Receiving Spironolactone for Dermatologic Indications

Published: 3 July 2026| Version 1 | DOI: 10.17632/49gpgn4kxj.1

Contributor:

Rebecca Zhang

Description

Supplementary for Hyperkalemia Risk in Women With Stage I and II Chronic Kidney Disease Receiving Spironolactone for Dermatologic Indications: A Single-Center Retrospective Cohort Study

Supplementary - Hyperkalemia Risk in Women With Stage I and II Chronic Kidney Disease Receiving Spironolactone for Dermatologic Indications

Description

Files

Categories

Licence